Opinion|Videos|November 1, 2023
Impact of 2023 Updated IDSA Guidelines on Antimicrobial Resistant Gram-Negative Infection Treatment
Author(s)Christian Sandrock, MD, MPH, FCCP
Dr Christian Sandrock evaluates the impact of 2023 updated IDSA guidelines on treatment decisions for patients with antimicrobial resistant gram-negative infections and for patients with multidrug-resistant pathogens.
Advertisement
Newsletter
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Contagion Live
1
Top Infectious Disease News Stories Week of December 20 - December 26
2
From Awareness to Prevention: Addressing the Infection–Mental Illness–Violence Continuum
3
WHO Finds Progress in Malaria Prevention Measures
4